Mode
Text Size
Log in / Sign up

CRRT after heart transplantation linked to preoperative hemoglobin and VIS score in cohort study

CRRT after heart transplantation linked to preoperative hemoglobin and VIS score in cohort study
Photo by National Institute of Allergy and Infectious Diseases / Unsplash
Key Takeaway
Consider preoperative hemoglobin and VIS score as potential perioperative risk factors for CRRT after heart transplantation.

This was a single-center retrospective cohort study of 213 heart transplantation recipients. The study examined perioperative risk factors for receiving continuous renal replacement therapy (CRRT) within 7 days after surgery and the association between CRRT and postoperative mortality.

Among 213 recipients, 30 (14.1%) received CRRT. The primary analysis found that preoperative hemoglobin was associated with a lower risk of CRRT (OR 0.963, 95% CI 0.937–0.986, p=0.003). In contrast, the Vasoactive-Inotropic Score (VIS) was associated with a higher risk of CRRT (OR 1.282, 95% CI 1.175–1.423).

Safety and tolerability data were not reported. The study was limited by its single-center retrospective design and a limited number of events (EPV=10). Internal validation was performed using bootstrap resamples, and model performance was assessed.

Given the observational design, the associations do not imply causation. The findings may not be generalizable beyond this single center. Clinicians should interpret these risk factors as hypotheses for further study rather than definitive practice guidance.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundHeart transplantation (HT) is an effective treatment for end-stage heart disease, but postoperative acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) is associated with poor outcomes. Although risk factors for AKI after HT have been well established, studies specifically focusing on CRRT as a clinical endpoint and employing rigorous predictive modeling remain limited. This study aims to identify perioperative risk factors for CRRT after HT and to develop a validated prediction model.MethodsThis single-center retrospective study included HT recipients from April 2018 to November 2023. Patients requiring CRRT within 7 days after surgery were compared with those who did not. Candidate predictors were pre-selected based on clinical rationale and previous literature. LASSO regression was used for variable selection to prevent overfitting. A multivariable logistic regression model was then constructed and internally validated using 1,000 bootstrap resamples. Model performance was assessed by discrimination (optimism-corrected AUC), calibration (calibration plot, Hosmer-Lemeshow test), overall fit (Brier score), and clinical utility (decision curve analysis). A time-dependent Cox proportional hazards model was used to evaluate the association between CRRT and postoperative mortality, thereby avoiding immortal time bias.ResultsAmong 213 recipients, 30 (14.1%) received CRRT. LASSO regression identified nine key predictors: preoperative hemoglobin, preoperative total bilirubin, preoperative ECMO use, cardiopulmonary bypass time, intraoperative blood loss, red blood cell transfusion volume, mechanical ventilation time, VIS score, and lactate peak. Considering the limited number of events (EPV = 10), three core variables were ultimately included in the multivariable model: preoperative hemoglobin (OR 0.963, 95%CI 0.937–0.986, p = 0.003), VIS score (OR 1.282, 95%CI 1.175–1.423, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.